Canadian Pharmacy Warns Normal-Weight Individuals with Metabolic Syndrome

Mar 27
08:37

2012

Remcel Mae P. Canete

Remcel Mae P. Canete

  • Share this article on Facebook
  • Share this article on Twitter
  • Share this article on Linkedin

Non-obese individuals with metabolic syndrome have raised risk for heart failure compared to obese patients without metabolic syndrome.

mediaimage

Non-obese individuals with metabolic syndrome have raised risk for heart failure compared to obese patients without metabolic syndrome.  

Metabolic syndrome symptoms include raised blood pressure,Canadian Pharmacy Warns Normal-Weight Individuals with Metabolic Syndrome Articles above normal insulin levels, extra body fat surrounding the waist, excessive triglycerides and/or irregular cholesterol levels, which increase the risk of stroke, heart illness and diabetes.  With these known symptoms, it’s easier to know when to buy Plavix

Study lead author Dr. Christina Voulgari, from the first department of cardiology at Athens University Medical School at Hippokration Hospital in Athens, Greece, stated that the results recommend that "we should focus not on weight loss at any given cost but (on) a healthier lifestyle." 

"Yes, in general, obesity is a bad thing," according to Dr. Robert Scott III, an associate professor of internal medicine at Texas A&M Health Science Center College of Medicine and a senior staff cardiologist at Scott & White in Temple, Texas. "But it's not everything. And here we have a bit of fine-tuning that suggests that the important thing with obesity tends to be the metabolic syndrome." 

"And that means," Scott further added, "that if you have this constellation of factors – high blood pressure, low HDL, high sugar levels – you are going to face a much higher risk for coronary heart disease and congestive heart failure even if you are not obese." Generic Plavix can largely help if you are in a budget.

But Dr. Gregg C. Fonarow, a professor of cardiovascular medicine at University of California, Los Angeles, said, "while the study drives home the notion that metabolic risk factors are key to heart disease risk, obesity is still a problem." 

The Greek researchers "are just looking at heart failure here," he noted. "But obesity also comes along with a higher risk for diabetes, cancer and shortened survival overall. So it's not that one's overall health in the long-term will not be adversely affected by being obese. Getting to a healthy body weight, of course, remains as important as ever."  This will prevent you from going to Canadian pharmacy as well. 

Metabolic syndrome is a combination of medical disorders that, when occurring together, increase the risk of developing cardiovascular disease and diabetes. Some studies have shown the prevalence in the USA to be an estimated 25% of the population, and prevalence increases with age. 

Metabolic syndrome is also known as metabolic syndrome X, cardiometabolic syndrome, syndrome X, insulin resistance syndrome, Reaven's syndrome (named for Gerald Reaven), and CHAOS (in Australia). 

Presently there are a couple of sets of defining criteria for metabolic syndrome set out by two different sources -- the International Diabetes Federation and the revised National Cholesterol Education Program. These are very similar and they identify individuals with a given set of symptoms as having metabolic syndrome. There are two differences, however: the IDF state that if BMI > 30 kg/m2, central obesity can be assumed, and waist circumference does not need to be measured. However, this potentially excludes any subject without increased waist circumference if BMI < 30. Conversely, the NCEP definition indicates that metabolic syndrome can be diagnosed based on other criteria. Also, the IDF uses geography-specific cut points for waist circumference while NCEP uses only one set of cut points for waist circumference regardless of geography. These two definitions are much more similar than the original NCEP and WHO definitions.